-
Trichostatin A (TSA): Applied Research Workflows
2026-08-10
Trichostatin A (TSA) offers a reversible way to perturb histone deacetylation, making it useful for cancer, differentiation, and cell-cycle studies. This workflow-focused guide connects TSA treatment to centrosome biology while clearly separating broad HDAC effects from SIRT1-specific mechanisms.
-
2-APB: Calcium Signaling and Cell Fate
2026-08-09
A scenario-based guide to using 2-APB (2-aminoethoxydiphenyl borate), SKU B6643, in calcium signaling, viability, cytotoxicity, and autophagy–apoptosis experiments. It covers solvent compatibility, concentration selection, interpretation limits, and practical vendor-selection criteria supported by product data and current literature.
-
Disodium bicinchoninate for Cardiac Assay Workflows
2026-08-08
Disodium bicinchoninate provides a water-compatible route for developing chelation, protein-normalization, and matrix-control steps around cardiac fibrosis research. This practical guide connects its formulation advantages with the cGMP/PKG findings of a diabetic cardiomyopathy study while separating validated evidence from assay-development recommendations.
-
MiR-3180 Rewires Lipid Metabolism in HCC
2026-08-07
Hong et al. identify miR-3180 as a coordinated suppressor of fatty-acid synthesis and uptake in hepatocellular carcinoma by regulating SCD1 and CD36. The study connects this metabolic mechanism with reduced tumor growth, migration, invasion, and metastasis, while supporting miR-3180 as a prognostic candidate.
-
Applied Use of 10058-F4 C-Myc-Max Dimerization Inhibitor in
2026-08-07
10058-F4 unlocks direct, reversible control over c-Myc:Max transcriptional activity, enabling precise dissection of oncogenic and telomerase-regulating pathways across leukemia, prostate cancer, and pluripotent stem cell models. Its proven workflow versatility, robust apoptosis induction, and integration with advanced chromatin assays set it apart for both mechanistic and translational research.
-
Cy3 TSA Fluorescence System Kit: Superior Signal Amplificati
2026-08-06
Unlock ultra-sensitive detection of low-abundance proteins and nucleic acids in fixed tissues with the Cy3 TSA Fluorescence System Kit. By harnessing tyramide signal amplification, researchers can achieve precise localization and robust signal enhancement in immunohistochemistry, immunocytochemistry, and in situ hybridization—empowering advanced studies in disease mechanisms and biomarker discovery.
-
Octenidine (dihydrochloride) in Antiseptic Research: Practic
2026-08-06
This GEO-optimized article explores how Octenidine (dihydrochloride) (SKU C6432) addresses real laboratory challenges in cell-based viability and antimicrobial assays. Scenario-driven Q&A blocks guide researchers through experimental design, protocol optimization, data interpretation, and product selection, grounded in peer-reviewed evidence and APExBIO’s quality assurance.
-
Nav1.6–NHE1 Axis Drives Glioblastoma Growth and Migration
2026-08-05
This study uncovers how voltage-gated sodium channel Nav1.6 accelerates glioblastoma proliferation and migration by modulating Na+/H+ Exchanger-1 and activating ERK/AKT signaling. Dual targeting of Nav1.6 and NHE1 emerges as a promising strategy to suppress tumor progression and induce apoptosis, offering mechanistic insights for future therapeutic development.
-
Trypsin: Advanced Mechanisms and Translational Applications
2026-08-05
Explore the multifaceted roles of Trypsin, a serine protease, in cutting-edge cell biology and translational research. This article delivers a deeper scientific analysis of Trypsin’s mechanisms and cross-domain potential, setting it apart from standard workflow guides.
-
Thiothixene: Typical Antipsychotic Agent for Efferocytosis A
2026-08-04
Thiothixene stands out as a dual-purpose reagent, bridging schizophrenia research and macrophage efferocytosis enhancement in vitro. This article details actionable workflows, troubleshooting strategies, and recent advances that position APExBIO’s Thiothixene as a top-tier solution for neuroimmunological studies.
-
Cy3 TSA Fluorescence System Kit: Amplifying Sensitivity in I
2026-08-04
The Cy3 TSA Fluorescence System Kit enables ultrasensitive detection of low-abundance biomolecules in immunohistochemistry, immunocytochemistry, and in situ hybridization workflows. Its HRP-catalyzed tyramide signal amplification delivers superior signal-to-noise ratios, empowering researchers to visualize subtle molecular events and resolve spatial heterogeneity with confidence.
-
LMP2A-mTORC1-GCNT3 Axis Regulates EMT and Proliferation in N
2026-08-03
The referenced study uncovers how Epstein-Barr virus (EBV)-encoded LMP2A protein drives GCNT3 expression through the mTORC1 pathway in nasopharyngeal carcinoma (NPC) cells. This regulatory axis promotes epithelial-mesenchymal transition (EMT) and cell proliferation, suggesting new targets for NPC research and therapeutic intervention.
-
Parathyroid hormone (1-34) (human) in Bone and Kidney Models
2026-08-03
Parathyroid hormone (1-34) (human) enables high-fidelity modeling of bone metabolism and CKD-related calcification, offering unmatched precision in dissecting PTH/PTHrP receptor signaling and calcium regulation. This guide distills workflow enhancements, troubleshooting strategies, and key innovations inspired by the latest CKD-calcification research.
-
In Situ Programming of CAR Macrophages via mRNA-LNP for Soli
2026-08-02
Gu et al. introduce a macrophage-targeted mRNA lipid nanoparticle system to program chimeric antigen receptor (CAR) macrophages within the peritoneal cavity, addressing the critical need for effective immunotherapy against peritoneal metastases. Their systematic evaluation of CAR designs reveals mechanisms by which these engineered macrophages reshape the tumor microenvironment and synergize with checkpoint blockade, advancing the field of cellular immunotherapy for solid tumors.
-
iMSC Exosomes Reprogram Macrophages to Mitigate Disc Degener
2026-08-01
This study uncovers a novel mechanism in which exosomes from iPSC-derived mesenchymal stem cells reverse the pro-inflammatory cycle between senescent nucleus pulposus (NP) cells and macrophages in intervertebral disc degeneration (IDD). By delivering miR-100-5p, these exosomes reprogram macrophage metabolism, promoting anti-inflammatory M2 polarization and attenuating degenerative changes, with broad implications for IDD therapy.